
SANA
Sana Biotechnology Inc.
$3.25
+$0.16(+5.18%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$737.20M
Volume
3.11M
52W Range
$1.26 - $7.30
Target Price
$8.67
Order:
Income Statement
Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|
OPERATING EXPENSES | ||||||
Operating Expenses | $356.9M | $272.6M | $293.1M | $272.7M | ||
Research & Development | $248.6M | $285.9M | $268.8M | $217.6M | ||
Research Expense | $248.6M | $285.9M | $268.8M | $217.6M | ||
Selling, General & Administrative | $50.4M | $71.6M | $73.3M | $64.0M | ||
General & Administrative Expenses | $50.4M | $71.6M | $73.3M | $64.0M | ||
Salaries & Wages | $22.4M | -- | -- | -- | ||
Depreciation & Amortization | $11.1M | $15.6M | $24.6M | $17.4M | ||
Depreciation & Amortization | $11.1M | -- | -- | -- | ||
Amortization | $140.6M | $140.6M | $140.6M | -- | ||
Other Operating Expenses | $-57.9M | -- | -- | $272.7M | ||
OPERATING INCOME | ||||||
Operating income | $-356.9M | $-272.6M | $-293.1M | $-272.7M | ||
EBITDA | $-222.2M | $-241.7M | $-245.4M | $-239.7M | ||
NON-OPERATING ITEMS | ||||||
Intinc | $676.0K | $3.8M | $9.9M | $10.5M | ||
Net Non-Operating Interest Income/Expense | $676.0K | $3.8M | $9.9M | $10.5M | ||
Other Income/Expense | $-305.0K | $-674.0K | $52.0K | $4.5M | ||
Other Special Charges | $305.0K | $-674.0K | $-52.0K | $-4.5M | ||
PRE-TAX INCOME | ||||||
EBIT | $-240.2M | $-269.5M | $-283.3M | $-266.8M | ||
Pre-Tax Income | $-240.2M | $-269.5M | $-332.2M | $-266.8M | ||
NET INCOME | ||||||
Net Income | $-355.9M | $-269.5M | $-283.3M | $-266.8M | ||
Net Income (Continuing Operations) | $-355.9M | $-269.5M | $-283.3M | $-266.8M | ||
Net Income (Discontinued Operations) | $-355.9M | $-269.5M | $-283.3M | $-266.8M | ||
Net Income (Common Stockholders) | $-355.9M | $-269.5M | $-283.3M | $-266.8M | ||
TOTALS | ||||||
Total Expenses | $356.9M | $272.6M | $293.1M | $272.7M | ||
SHARE & EPS DATA | ||||||
Average Shares Outstanding | $166.4M | $188.3M | $194.5M | $230.9M | ||
Average Shares Outstanding (Diluted) | $166.4M | $188.3M | $194.5M | $230.9M | ||
Shares Outstanding | $189.5M | $191.4M | $237.8M | $225.0M | ||
Basic EPS | $-2.14 | $-1.43 | $-1.46 | $-1.16 | ||
Basic EPS (Continuing Operations) | $-2.14 | $-1.43 | $-1.46 | $-1.16 | ||
Diluted EPS | $-2.14 | $-1.43 | $-1.46 | $-1.16 | ||
Diluted EPS (Continuing Operations) | -- | $-1.43 | $-1.46 | $-1.16 | ||
OTHER METRICS | ||||||
Other Gand A | $50.4M | $71.6M | $73.3M | $64.0M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | SANA | $3.25 | +5.2% | 3.11M |
3 | ||||
4 | ||||
5 | ||||
6 |